The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence.
 
Erica C. Koch Hein
Consulting or Advisory Role - MSD; Novartis; Novartis
Speakers' Bureau - MSD; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Pfizer; Roche Pharma AG
 
Maysa Vilbert
No Relationships to Disclose
 
Ian Hirsch
No Relationships to Disclose
 
Mauricio Fernando Ribeiro
Honoraria - Bristol-Myers-Squibb
 
Luke Mantle
No Relationships to Disclose
 
Cynthia Fournier
Honoraria - Janssen
Consulting or Advisory Role - Sanofi; Sun Pharma
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Adaptimmune; Bristol-Myers Squibb; EMD Serono; Genzyme; GlaxoSmithKline; GlaxoSmithKline; IDEAYA Biosciences; Immunocore; Immunovaccine; Instil Bio; Iovance Biotherapeutics; LaRoche Posay; Medison; Merck; Novartis; Pfizer; Regeneron; Sanofi; Sun Pharma
Research Funding - Merck (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Takara Bio (Inst)
Expert Testimony - Merck
 
Anna Spreafico
Honoraria - Immunocore; Medison
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; Medison; Merck
Research Funding - Alkermes (Inst); ALX Oncology (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Nubiyota (Inst); Pfizer (Inst); Replimune (Inst); Roche (Inst); Seagen (Inst); SERVIER (Inst); Surface Oncology (Inst); Symphogen (Inst); Treadwell Therapeutics (Inst)
 
Samuel Saibil
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Immunocore; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Iovance Biotherapeutics